Award recordCONTRACT

GUARDIAN PHARMACY OF INDIANAPOLIS NUCLEAR, LLC

PIID 36C25019P0558· VHA· 250-NETWORK CONTRACT OFFICE 10 (36C250)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $36,393 net obligations· UEI DR3USD14LYJ4· IN

Description

NUCLEAR MEDICINE RADIOPHARMACEUTICALS - MODIFICATION TO DE-OBLIGATE EXCESS FUNDS.

Base award description: NUCLEAR MEDICINE RADIOPHARMACEUTICALS

First action · last action
2018-12-28 · 2019-03-28
Transactions
2
First transaction's obligation
$67,740
Base + all options value (sum of deltas)
$36,393
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$67,740$0Base award · 2018-12-28 · this action $67,740 · running total $67,740Modification P00001 · 2019-03-28 · this action -$31,347 · running total $36,393
  • Base2018-12-28+$67,740= $67,740
  • Mod P000012019-03-28-$31,347= $36,393
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-12-28+$67,740$67,740NUCLEAR MEDICINE RADIOPHARMACEUTICALS
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-03-28−$31,347$36,393NUCLEAR MEDICINE RADIOPHARMACEUTICALS - MODIFICATION TO DE-OBLIGATE EXCESS FUNDS.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DR3USD14LYJ4)

AwardOffice · PSC / listingNet obligationsFY
36C25026N0072250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$350,000FY2026
36C25025N0041250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$350,003FY2025
36C25024N0057250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$305,179FY2024
36C25023D0083250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C25019P0752250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$11,904FY2019
36C25019P0028250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$102,689FY2019

Other recipients under 6505 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25026P0991ASD SPECIALTY HEALTHCARE, LLC250-NETWORK CONTRACT OFFICE 10 (36C250)$43,680FY2026
36C25026F0668COSETTE PHARMACEUTICALS, INC.250-NETWORK CONTRACT OFFICE 10 (36C250)$10,398FY2026
36C25026N0655PROGENICS PHARMACEUTICALS INC250-NETWORK CONTRACT OFFICE 10 (36C250)$721,744FY2026
36C25026N0616AMERICAN NATIONAL RED CROSS, THE250-NETWORK CONTRACT OFFICE 10 (36C250)$37,180FY2026
36C25026D0061AMERICAN NATIONAL RED CROSS, THE250-NETWORK CONTRACT OFFICE 10 (36C250)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25019P0558_3600_-NONE-_-NONE- · retrieved 2026-09-26.